Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

NCT00722917 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

323

Enrollment

INDUSTRY

Sponsor class

Stopped Animal Toxicity Findings

Conditions

Diabetes Mellitus

Interventions

DRUG: TAK-379
DRUG: TAK-379
DRUG: TAK-379
DRUG: Pioglitazone
DRUG: Placebo

Sponsor

Takeda